Infectious Diseases Research Centre |
|---|
RESEARCH
Addressing National Needs/ Issues (on-going: 2002-2005)
IRPA PRIORITISED RESEARCH
Antibiotic Resistance Research Programme
10 projects : 3 (IMR), 4 (UM), 2 (USM) and 1 (VRI)
Addressing the issues of epidemiology, antibiotic use in animal, clinical pattern and mechanism of resistance
Hepatocellular Carcinoma Virological markers in HCC
MOH R&D GRANT & OTHERS
Incidence & molecular epidemiology of J.E in Malaysia
Seroepidemiology of mumps, measles and rubella
Phenotypic and molecular characterisation of pathogenic leptospira and epidemiology of leptospirosis in Malaysia (IRPA)
Virological & clinical prognostic factor of enterovirus causing HFMD (MOH)
Innovation, development & basic science (on-going: 2002-2005)
Maggots therapy for wound treatment (IRPA)
Maggot Therapy in First Patient in Lumut Navy Hospital in May 2003
Intractable wound due to diabetes
Sterile maggots on filter paper
Application of maggots
Bandaging wound after application of larvae
Appearance of fresh tissue after 1 week. Patient discharged on 3rd week after 3 treatments.
ACAROLOGY & ALLERGENS
Preparation & standardisation of extracts of local species of cockroaches for diagnosis of allergies
IRPA funding
6 skin prick test solutions have been standardised
Positive skin test rates among rhinitis patients against the 6 species ranged between 31.3% to 56.2% .
Distribution of mites, weevil & their allergen level in rice & its raw processed products
Funded by Malaysian Toray Science Foundation
To determine distribution of mites and weevils in rice & rice products
Higher contamination rate from commercial sources (31.3%) compared to individual houses (25%).
Rice from farmers showed lowest contamination (4%).
MEDICAL ENTOMOLOGY
Development of new technique to detect dengue virus in mosquito
Funded by WHO/TDR
Specific outcomes
- Specific proteins associated with dengue
- Antibodies against these proteins
- Development of ELISA format to detect the protein in mosquitoes
30% progress, 2 specific proteins found so far.
Development of comprehensive rapid test for insecticide resistance
IRPA funded
Expected outcomes
- Rapid detection kit for use in the field
80% progress, kit has been tested in the field and found to be useful
Cytotoxicity activities of Malaysian isolates of Bacillus thuriengiensis
Funded by Toray foundation & IMU
Expected outcomes
25% progress
Several isolates exhibited high in-vitro cytotoxicity to leukaemic and cervical cancer cell lines.
One showing 84% cytotoxicity against leukaemic cell line without affecting normal cells.
MALARIA IMMUNOLOGY & PROTECTION STUDIES
Synthetic malaria protein and T-cell response – measuring cellular immune response (IMR-Nagasaki Tropical Disease Institute collaboration)
Screening for malaria parasite protein fragments that can stimulate T-cell response (measured by interferon gamma production)
20 different protein fragments were tested against T-cells harvested from 22 volunteers from malaria endemic area.
9 protein fragments produced strong T-cell response.
IDRC: Responding to specific requests (2003-2004)
EIA project for Tenaga Nasional in Hulu Trengganu
Operational research related to National Filariasis Elimination Programme: Effect of interrupted mass treatment on transmission
Environmental Impact Assessment (EIA) studies
One request from TNB to EIA (health) for their Hulu Trengganu Dam Project
Assess impact on soil transmitted helminths (STH) and vector-, food- and water-borne diseases
Despite good overall safe water supply coverage (88.1%) and proper sewage system (91.4%), soil, food and water-borne diseases are still prevalent.
Infection rates range:-
– STH: 0-55.2%
–Amoebiasis: 0-35.3%
– Giardiasis: 0-17.6%
![]()
![]()
Effect of interrupted mass treatment on disease transmission
Global Lymphatic Filariasis Elimination Strategy: Annual mass treatment with DEC for 5 consecutive years.
1992-1994: 2 sites in Gerik treated for 2 years to compare single and standard DEC dose.
Treatment was not continued
After 8 years (2003), microfilaria (Mf) prevalence rose from 6.8% to 9.8%, Mf density from 0.89 ± 4.16 to 4.03 ± 77 per 60 uL blood.
Supports rationale for the 5-years mass treatment
![]()
IDRC: International collaboration-exporting expertise (2000-2004)
![]()
![]()
IMR role as WHO Regional Centre for Training & Research in Tropical Diseases and Nutrition
Funding through WPRO Small (USD20,000) Research Grant for Inter-Countries Collaborative Research
Epidemiology of malaria and vector distribution in Lao PDR (Sekong & Attepeau Provinces).
Better understanding of malaria epidemiology in southern provinces: malaria transmission throughout the year – wet & dry seasons
Published for the first time evidence of An. dirus as principle vector in Lao PDR
Significant input towards improved malaria control approach & strategies
Staining methods for rapid identification of malaria parasites Field stain for new simian parasite species
TORCHES ( ( To xoplasmosis, R ubella, C ytomegalovirus, He rpes, S yphillis) group of diseases
implementation of the national rubella immunisation programme
Nosocomial infection research
produced useful guidelines to minimise hospital infections in the country
Serology diagnosis for melioidosis and legionellosis
Development of an in-house test methods based on immunoflourescent antibody techniques to provide services for the public and private hospitals
Rapid detection of oxidases for the detection of insecticide resistance
Rapid test kit for detection of pirethroid poisoning
Production process for a Malaysian isolate of Bacillus sphaericus
Environmental friendly mosquitocidal biological agent
Rapid detection of insensitive acetylcholinesterase for the detection of insecticide resistance
Rapid test kit for detection of resistance caused by organophosphate and carbamate
Detection of acetylcholinesterase in human oral fluid (saliva)
The first method for the detection of acetylcholinesterase in human saliva in insecticide poisoning and neurological disorders
Insecticide-impregnated emulsion paint
Elmusion paint formulation impregnated with pyrethroid and deltamethrine to be used against insects and as a vector control agent
Study on Aedes mosquito larvae in dengue infection
Development of MOSBAC to destroy Aedes mosquito larvae using a combination of a chemical agent and Bacillus thuringiensis strain H14 (Bti)
FUTURE RESEARCH
26 projects in 4 major Research programmes:
Vector-borne diseases & their vector
- 13 projects
STD & HIV
- 4 projects
Zoonotic infection and the environment
- 3 projects
New technologies & innovation
- 6 projects
Funding: estimated RM15.25 million over 8-10 years
IRPA
MOH
International bodies
Tick-Borne Diseases Research Programme
Sporadic studies: tick-borne diseases are endemic, significant public health problem
Increasing urbanisation, commercial farming, eco-tourism increasing the risk
Limited current information on magnitude of problem, vectors & risk of transmission.
No control activities & surveillance (notification to VBDCP) is limited by problem of diagnosis
Potential niche area of research excellence & commercialisation, particular diagnostic test kits
IMR is the lead agency, 12 projects by IMR, UM, MACRES, UKM, Sarawak Health Dept & UNIMAS
IRPA-PR: Concept approved
IMR/UM/UKM/UNIMAS/MACRES/Sarawak Hlth Dept
Preparedness for emerging and reemerging diseases
IRPA-PR: Brief proposal approved
Mosquito Genome Project
To completely sequence the genome of Aedes aegypti and Aedes albopictus , vectors of dengue
Collaborators: Celeron Co.
Expected outcomes:
- Complete genomes of both mosquitoes
- Design of novel control methods based on genomes of these species
Transgenic mosquito project
Development of transgenic mosquitoes refractory to transmission of diseases
Collaborators: CDC Fort Collins, USA
Expected outcomes:
- Production of transgenic strains of mosquito vectors
- Release of transgenic vectors to replace field populations
- Interruption of disease transmission